• Exchange: EN Paris
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GTCL:FP

5.5000 EUR 0.0500 0.90%

As of 11:10:04 ET on 12/22/2014.

Snapshot for Genticel SA (GTCL)

Open: 5.5000 Day's Range: 5.4000 - 5.5100 Volume: 9,140
Previous Close: 5.5500 52wk Range: 4.7500 - 7.4000 1-Yr Rtn: -

Stock Chart for GTCL

No chart data available.
  • GTCL:FP 5.5000
  • 1D
  • 1M
  • 1Y
5.5500
Interactive GTCL Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GTCL

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. CAC -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.5200
Est. PEG Ratio -
Market Cap (M EUR) 84.92
Shares Outstanding (M) 15.44
30 Day Average Volume 6,266
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GTCL

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GTCL

Genticel SA researches and develops biopharmaceutical products. The Company offers therapeutic vaccines for the prevention and treatment of human papillomavirus. Genticel conducts business in France.

Benedikt TimmermanChairman-Mgmt Bd/CEO/FounderMartin KochChief Financial Officer
Marie Christine BisseryChief Scientific OfficerSophie OlivierChief Medical Officer
More Company Profile & Key Executives for GTCL

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement

Press Releases for GTCL

Advertisement
Sponsored Links
Advertisements
sec ||= nil